GT Biopharma, Inc. (GTBP) Financials
GTBP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 16.1 million | 6.1 million |
2023-06-30 | 18.1 million | 6.4 million |
2023-03-31 | 20.1 million | 7.0 million |
2022-12-31 | 16.7 million | 5.0 million |
GTBP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.0 million | 862000 |
2023-06-30 | -1.9 million | 259000 |
2023-03-31 | -2.9 million | 646000 |
2022-12-31 | -4.3 million | 1.3 million |
GTBP Net Income
No data available :(
GTBP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 16.0 million | - | 92000 |
2023-06-30 | 18.0 million | - | 120000 |
2023-03-31 | 19.9 million | - | 147000 |
2022-12-31 | 16.5 million | - | 174000 |
GTBP Shares Outstanding
GTBP Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.4 million | 1.8 million | - |
2023-06-30 | - | 2.1 million | 1.5 million | - |
2023-03-31 | - | 1.7 million | 2.0 million | - |
2022-12-31 | - | 2.8 million | 1.9 million | 1.1 million |
GTBP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | - | - |
GTBP
Price: $3.06
52 week price:
Earnings Per Share: -5.58 USD
P/E Ratio: -0.54
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 64789
Market Capitalization: 5.4 million